Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain

dc.contributor.authorFernández de Larrea Baz, Nerea
dc.contributor.authorMichel, Angelika
dc.contributor.authorRomero, Beatriz
dc.contributor.authorPérez Gómez, Beatriz
dc.contributor.authorMoreno Aguado, Víctor
dc.contributor.authorMartín Sánchez, Vicente
dc.contributor.authorDierssen Sotos, Trinidad
dc.contributor.authorJiménez Moleón, José Juan
dc.contributor.authorCastilla, Jesús
dc.contributor.authorTardón, Adonina
dc.contributor.authorRuiz, Irune
dc.contributor.authorPeiró Pérez, Rosana
dc.contributor.authorTejada, Antonio
dc.contributor.authorChirlaque, María Dolores
dc.contributor.authorButt, Julia A.
dc.contributor.authorOlmedo Requena, Rocío
dc.contributor.authorGómez Acebo, Inés
dc.contributor.authorLinares, Pedro
dc.contributor.authorBoldo, Elena
dc.contributor.authorCastells Garangou, Antoni
dc.contributor.authorPawlita, Michael
dc.contributor.authorCastaño-Vinyals, Gemma
dc.contributor.authorKogevinas, Manolis
dc.contributor.authorSanjosé Llongueras, Silvia de
dc.contributor.authorPollán, Marina
dc.contributor.authorCampo, Rosa del
dc.contributor.authorWaterboer, Tim
dc.contributor.authorAragonès Sanz, Núria
dc.date.accessioned2019-09-12T10:05:00Z
dc.date.available2019-09-12T10:05:00Z
dc.date.issued2017-05-29
dc.date.updated2019-09-12T10:05:00Z
dc.description.abstractBackground: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain.Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to >= 4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI).Results: H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71-1.16). Among H. pylori seropositive subjects, seropositivity to Cag delta showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women.Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec675930
dc.identifier.issn1664-302X
dc.identifier.pmid28611733
dc.identifier.urihttps://hdl.handle.net/2445/139819
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fmicb.2017.00888
dc.relation.ispartofFrontiers in Microbiology, 2017, vol. 8
dc.relation.urihttps://doi.org/10.3389/fmicb.2017.00888
dc.rightscc-by (c) Fernández de Larrea Baz, Nerea et al., 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationHelicobacteri pilòric
dc.subject.classificationCàncer colorectal
dc.subject.otherHelicobacter pylori
dc.subject.otherColorectal cancer
dc.titleHelicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
675930.pdf
Mida:
1.65 MB
Format:
Adobe Portable Document Format